Keytruda nabs key lung cancer nod in China. But are blockbuster sales really attainable? - FiercePharma

Keytruda nabs key lung cancer nod in China. But are blockbuster sales really attainable?  FiercePharma

Less than a year after securing its first Chinese approval, in previously treated metastatic melanoma patients, Merck & Co.'s Keytruda has leaped ahead of ...